A role for protein kinase C δ in the differential sensitivity of MCF-7 and MDA-MB 231 human breast cancer cells to phorbol ester-induced growth arrest and p21WAFI/CIP1 induction

Cancer Letters

Volumn 172, Issue 1, 2001, Pages 43-53

  Shanmugam, Malathy ^a   Krett, Nancy L ^a   Maizels, Evelyn T ^a   Murad, Faris M ^a   Rosen, Steven T ^a   Hunzicker Dunn, Mary ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Breast cancer; Growth; p21WAF1 CIP1; Protein kinase C

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; ESTROGEN RECEPTOR; ISOPROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; PROTEIN KINASE C ACTIVATOR; PROTEIN KINASE C DELTA; PROTEIN KINASE C ETA; PROTEIN P21; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER INHIBITION; CELL STRAIN MCF 7; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; REGULATORY MECHANISM;

ACETOPHENONES; ANIMALS; BENZOPYRANS; BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOGENS; CELL DIVISION; CELL MEMBRANE; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; CYTOSOL; DETERGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; ISOENZYMES; LUCIFERASES; OCTOXYNOL; PLASMIDS; PROTEIN ISOFORMS; PROTEIN KINASE C; PROTEIN KINASE C-DELTA; RATS; RECEPTORS, ESTROGEN; TETRADECANOYLPHORBOL ACETATE; TRANSFECTION; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0035935251     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(01)00602-4     Document Type: Article

References (52)

1. Protein kinase C- A question of specificity
2. The extended protein kinase C superfamily
3. Antagonistic actions of phorbol ester in mammalian G0 to G1 to S cell cycle transition
4. Biological response to phorbol ester determined by alternative G1 pathways
5. Phorbol esters inhibit the proliferation of MCF-7 cells
6. Phorbol esters induce death in MCF-7 breast cancer cells with altered expression of protein kinase C isoforms
7. Linking protein kinase C to cell-cycle control
8. Involvement of p21 in the PKC-induced regulation of the G2/M cell cycle transition
9. Defects in p21WAF1/CIP1 Rb, and c-myc signaling in phorbol ester-resistant cancer cells
10. Protein kinase C isozyme-mediated cell cycle arrest involves induction of p21waf1/cip1 and p27kip1 and hypophosphorylation of the retinoblastoma protein in intestinal epithelial cells
11. The cyclin-dependent kinase inhibitor p21cip1 mediates the growth inhibitory effect of phorbol esters in human venous endothelial cells
12. Up-regulation of p21WAF1 by phorbol ester and calcium in human keratinocytes through a protein kinase C-dependent pathway
13. Contribution of protein kinase C to p53-dependent WAF1 induction pathway after heat treatment in human glioblastoma cell lines
14. The alpha isoform of protein kinase C mediates phorbol ester-induced growth inhibition and p21 (cip1) induction in HCl1 mammary epithelial cells
15. Gi phase progression: Cycling on cue
16. Cyclins and cancer II: Cyclin D and CDK inhibitors come of age
17. Involvement of MAP kinase-independent protein kinase C signaling pathway in the EGF-induced p21 (WAF1/Cip1) expression and growth inhibition of A431 cells
18. Up-regultion of p21WAF1 expression in myeloid cells is activated by the protein kinase C pathway
19. Linking protein kinase C to the cell cycle: Ecotpic expression of PKC eta in NIH3T3 cells alters the expression of cyclins and Cdk inhibitors and induces adipogenesis
20. Protein kinase C desensitization by phorbol esters and its impact on growth of human breast cancer cells
21. Correlation between hormone dependency and the regulation of EGF receptor by tumor promoters in human mammary carcinoma cells
22. + -dependent protein kinase in human breast cancer cells
23. Phorbol ester and bryostatin effects on growth and the expression of oestrogen responsive and TGF-beta 1 genes in breast tumour cells
24. PKC subspecies in estrogen receptor-positive and negative human breast cancer cell lines
25. Regulation of protein kinase C delta by estrogen in the MCF-7 human breast cancer cell line
26. Selective regulation of expression of PKC isotypes in MDR-resisitant MCF-7 cells. Fun ctional significance of enhanced expression of PKC-alpha
27. MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype
28. Protein measurement with the folin phenol reagent
29. 'Western blotting:' Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A
30. Protein kinase C delta activates the MEK-ERK pathway in a manner independent of ras and dependent on Raf
31. Activation of the mitogen activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes
32. WAF1, a potential mediator of p53 tumor suppression
33. Activation of the human mitochondrial transcription factor A gene by nuclear respiratory factors: A potential regulatory link between nuclear and mitochondrial gene expression in organelle biogenesis
34. Protein kinase C delta inhibits the proliferation of vascular smooth muscle cells by suppressing Gi cyclin expression
35. Kip1
36. Cell division arrest induced by phorbol ester in CHO cells overexpressing protein kinase C-delta subspecies
37. Overexpression of protein kinase C-delta and -epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity
38. Ras-dependent signal transduction is indespensible but not sufficient for the activation of APi/Jun by PKC delta
39. Opposite effects of the overexpression of protein kinase Cgamma and delta on the growth properties of human glioma cell line U251 MG
40. Enhancement of migration by protein kinase C alpha and inhibition of proliferation and cell cycle progression by protein kinase C delta in capillary endothelial cells
41. Protein kinase C delta inhibits the proliferation of vascular smooth muscle cells by suppressing Gi cyclin expression
42. The broad specificity of dominant inhibitory protein kinase C mutants infers a common step in phosphorylation
43. Protein kinase C delta activates the MEK-ERK pathway in a manner independent of ras and dependent on raf
44. Protein kinase C delta (PKCdelta) inhibits the expression of glutamine synthase in glial cells via the PKCdelta regulatory domain and its tyrosine phosphorylation
45. Both the catalytic and regulatory domains of protein kinase C chimeras modulate the proliferative properties of NIH 3T3 cells
46. Rottlerin, a novel protein kinase inhibitor
47. Protein kinase C-mediated bidirectional regulation of DNA synthesis, RB protein phosphorylation, and cyclin-dependent kinases in human vascular endothelial cells
48. Growth inhibition by protein kinase C late in mitogenesis
49. Transcriptional regulation of the p21(WAF1/CIP1) gene
50. Differential effects of protein kinase C agonists on prostaglandin production and growth in human breast cancer cells
51. p21WAF1 expression by an activator of protein kinase C is regulated mainly by the post-transcriptional level in cells lacking p53: Important role of RNA stabilization
52. A phorbol ester receptor/protein kinase, nPKC eta, a new member of the protein kinase C family predominantly expressed in lung and skin